Complex analysis of cyclin D1 expression in mantle cell lymphoma: Two cyclin D1-negative cases detected

Journal of Clinical Pathology

Volumn 62, Issue 10, 2009, Pages 948-950

  Stefancikova, L ^a,b   Moulis, M ^a,b   Fabian, P ^c   Falkova, I ^a   Vasova, I ^a   Kren, L ^a   Macak, J ^a   Smardova, J ^a,b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN D3; MESSENGER RNA;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; CYCLIN D2; FEMALE; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEOPLASM PROTEINS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 70349667492     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.063701     Document Type: Article

References (10)

1. Remstein ED, Kurtin PJ, Buno I, et al. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Brit J Haematol 2000;110:856-862 (Pubitemid 30804470)
2. Uchimaru K, Taniguchi T, Yoshikawa M, et al. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 1997;89:965-974 (Pubitemid 27121290)
3. Torlakovic E, Nielsen S, Vyberg M. Antibody selection in immunohistochemical detection of cyclin D1 in mantle cell lymphoma. Am J Clin Pathol 2005;124:782-789 (Pubitemid 41532513)
4. Swerdlow SH, Campo E, Harris NL, et al, eds. Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008.
5. Fu K, Weisenburger DD, Greiner TC, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005;106:4315-4321 (Pubitemid 41775942)
6. Wlodarska I, Dierickx D, Vanhentenrijk V, et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008;111:5683-5690
7. Gesk S, Klapper W, Martin-Subero JI, et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006;108:1109-1110 (Pubitemid 44154656)
8. Rosenwald A, Wright G, Wiesner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-197 (Pubitemid 37443390)
9. Yatabe Y, Suzuki R, Tobinai K, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1- positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000;95:2253-2261 (Pubitemid 30167722)
10. Chuang SS, Huang WT, Hsieh PP, et al. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathol Int 2006;56:440-448